Free Access
Reprod. Nutr. Dev.
Volume 45, Number 2, March-April 2005
Page(s) 175 - 183
References of Reprod. Nutr. Dev. 45 175-183
  1. Escobar J, Van Alstine WG, Baker DH, Johson RW. Growth performance and whole-body composition of pigs experimentally infected with Mycoplasma hyopneumoniae. J Anim Sci 2002, 80: 384-391 [PubMed].
  2. Reeds PJ, Jahoor F. The amino acid requirements of disease. Clin Nutr 2001, 20: 15-22.
  3. Melchior D, Sève B, Le Floc'h N. Chronic lung inflammation affects amino acid concentrations in pigs. J. Anim Sci 2004, 82: 1091-1099.
  4. Saito K, Markey SP, Heyes MP. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neurosciences 1992, 51: 25-39.
  5. Brown RR, Ozaki Y, Datta SP. Borden EC, Sondel PM, Malone DG. Implications of interferon-induced tryptophan catabolism in auto-immune diseases and AIDS. Adv Exp Med Biol 1991, 294: 425-435 [PubMed].
  6. Takikawa O, Yoshida R, Kido R, Hayaishi O. Tryptophan degradation in mice initiated by indoleamine 2,3 -dioxygenase. J Biol Chem 1986, 261: 3648-3653 [PubMed].
  7. Takikawa O, Kuroiwa T, Yamazaki F, Kido R. Mechanism of Interferon-gamma Action. J Biol Chem 1988, 263: 2041-2048 [PubMed].
  8. Fujigaki S, Saito K, Sekikawa K, Tone S, Takikawa O, Fuji H, Wada H, Noma A, Seishima M. Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-$\gamma$-independent mechanism. Eur J Immunol 2001, 31: 2313-2318 [CrossRef] [PubMed].
  9. Hansen AM, Driussi C, Turner V, Takikawa O, Hunt NH. Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue. Redox Report 2000, p 5.
  10. Yamazaki F, Kuroiwa T, Takikawa O, Kido R. Human indolylamine 2,3-dioxygenase. J Biochem 1985, 230: 635-638.
  11. Yoshida R, Yoshihiro U, Nakata K, Watanabe Y, Hataishi O. Specific induction of Indoleamine 2, 3-dioxygenase by bacterial lipopolysaccharride in the mouse lung. Arch Biochem. Biophys 1981, 212: 629-637.
  12. Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984, 81: 908-912 [PubMed].
  13. Christen S, Peterhans E, Stocker R. Antioxydant activities of some tryptophan metabolites: Possible implication for inflammatory diseases. Proc Natl Acad Sci USA 1990, 87: 2506-2510 [PubMed].
  14. Mellor AL, Munn DA. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunology Today 1999, 20: 469-473 [CrossRef] [PubMed].
  15. Edwards JF, Slauson DO. Complete Freund's adjuvant-induced pneumonia in swine: a model of interstitial lung disease. J Comp Pathol 1983, 93: 353-361 [CrossRef] [PubMed].
  16. Widner B, Werner ER, Schennach H, Fuchs D. An HPLC method to determine tryptophan and kynurenine in serum simultaneously. Tryptophan, serotonin, and melatonin: basic aspects and applications. Plenum, New York, 1999.
  17. Eckersall PD, Saini PK, McComb C. The acute phase response of acid soluble glycoprotein, $\alpha$1-acid glycoprotein, ceruloplasmin, haptoglobin and C-reactive protein, in the pig. Vet Immunol Immunopathol 1996, 51: 377-385 [PubMed].
  18. Gruys E, Obwolo MJ, Toussaint MJM. Diagnostic significance of the major acute phase proteins in veterinary clinical chemistry: a review. Vet Bull 1994, 64: 1009-1018.
  19. Lestage J. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun 2002, 16: 596-601 [CrossRef] [PubMed].
  20. Saito K, Markey SP, Heyes MP. Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. Brain Res 1991, 540: 353-356 [CrossRef] [PubMed].
  21. Däubener W, MacKenzie CR. Parasites, Bacteria and virus: all under the control of IDO? University of Padova, Italy. International study group for tryptophan research, 2002, p 26.
  22. MacKenzie CR, Hadding U. Interferon-gamma_induced activation 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 1998, 178: 875-878 [PubMed].
  23. Thomas SR, Stocker R. Redox reactions related to indoleamines 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Report 1999, 45: 199-220.
  24. Goda K, Hamane Y, Kishimoto R, Ogishi Y. Radical scavenging properties of tryptophan metabolites. Adv Exp Med Biol 1999, 467: 397-401 [PubMed].
  25. Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from lethal anti-fetal immune responses. J Reprod Immunol 2001, 52: 5-13 [CrossRef] [PubMed].
  26. Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 2002, 168: 3771-3776 [PubMed].
  27. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999, 189: 1363-1372 [CrossRef] [PubMed].
  28. Grohmann U, Fallarino F, Pucetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003, 24: 242-248 [CrossRef] [PubMed].
  29. Frumento G, Rotondo R, Tonetti M, Damonte G. Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002, 196: 459-468 [CrossRef] [PubMed].